Senti Biosciences Inc
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | +16.8% | -14.4% | +39.2% | +0.4% | +36.8% | -112.6% | – | -27.1% | -72.8% | +30.6% | +0.0% | -100.0% | – | – | -100.0% | – | – | – | -27.3% | +6.3% | – | |
| – | – | – | -73.5% | +308.0% | -2.3% | +71.6% | -40.5% | -8.4% | -1.6% | +30.4% | +2,021.5% | -94.3% | -0.9% | +0.4% | – | – | – | – | -38.8% | -1.2% | – | – | – | |
| – | – | – | – | -126.0% | – | +1,078.7% | +36.8% | -112.6% | – | -176.8% | – | -678.0% | – | – | – | – | – | – | – | – | – | -4,162.5% | – | |
| – | – | – | +26.5% | -0.6% | +22.7% | +40.3% | -29.5% | +40.6% | -26.1% | -9.6% | +48.5% | +0.3% | -6.6% | +4.4% | -2.7% | -12.9% | +23.1% | +5.6% | +7.3% | -26.2% | -31.9% | +47.1% | – | |
| – | – | – | +65.1% | -26.0% | -0.2% | +164.0% | -28.0% | +9.2% | -10.2% | -1.9% | -12.3% | -17.1% | -2.8% | -38.1% | +39.0% | +56.0% | -29.7% | +5.5% | -15.0% | +1.6% | -1.4% | +16.9% | – | |
| – | – | – | +39.8% | -13.8% | +11.3% | +93.0% | -28.9% | +21.9% | -22.7% | -2.7% | +195.9% | -61.6% | -12.5% | -19.9% | +28.0% | -3.3% | +11.5% | -6.6% | +10.6% | -25.0% | -9.4% | +20.2% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | +52,192.5% | -95.5% | +0.0% | +105.2% | -28.6% | – | – | +0.0% | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | +125.0% | -357.4% | – | – | – | – | – | – | – | +0.0% | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -1,922.3% | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.